# Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

> **NCT02253407** · PHASE4 · COMPLETED · sponsor: **Serum Institute of India Pvt. Ltd.** · enrollment: 341 (actual)

## Conditions studied

- Immune Response to MMR Vaccine

## Interventions

- **BIOLOGICAL:** MMR vaccine

## Key facts

- **NCT ID:** NCT02253407
- **Lead sponsor:** Serum Institute of India Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2018-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253407, "Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02253407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*